XWM
KURA icon

Xcel Wealth Management’s Kura Oncology KURA Stock Holding History

Xcel Wealth Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$776K Sell
95,393
-23,453
-20% -$201K 0.21% 81
2025
Q4 		$1.23M Buy
118,846
+16,525
+16% +$173K 0.31% 66
2025
Q3 		$906K Buy
+102,321
New +$729K 0.24% 74

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Xcel Wealth Management's KURA Position: Q1 2026 in Review

Xcel Wealth Management reduced its Kura Oncology (KURA) stake by 20% in Q1 2026, selling an estimated $201K and leaving 95,393 shares worth $776K. The position accounts for 0.21% of the portfolio, ranked #81.

Xcel Wealth Management first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.23M in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Xcel Wealth Management held 95,393 shares of Kura Oncology worth $776K as of Q1 2026.
  • Xcel Wealth Management sold 23,453 Kura Oncology shares in Q1 2026, an estimated $201K.
  • Kura Oncology made up 0.21% of Xcel Wealth Management's portfolio in Q1 2026, its #81 holding.
  • Xcel Wealth Management first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • Xcel Wealth Management's Kura Oncology position peaked at $1.23M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Xcel Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.